Abstract:Somatic cell nuclear transfer (SCNT) has been proved capable of reprogramming various differentiated somatic cells into pluripotent stem cells. Recently, induced pluripotent stem cells (iPS) have been successfully derived from mouse and human somatic cells by the over-expression of a combination of transcription factors. However, the molecular mechanisms underlying the reprogramming mediated by either the SCNT or iPS approach are poorly understood. Increasing evidence indicates that many tumor pathways play roles in the derivation of iPS cells. Embryonal carcinoma (EC) cells have the characteristics of both stem cells and cancer cells and thus they might be the better candidates for elucidating the details of the reprogramming process. Although previous studies indicate that EC cells cannot be reprogrammed into real pluripotent stem cells, the reasons for this remain unclear. Here, nuclei from mouse EC cells (P19) were transplanted into enucleated oocytes and pluripotent stem cells (P19 NTES cells) were subsequently established. Interestingly, P19 NTES cells prolonged the development of tetraploid aggregated embryos compared to EC cells alone. More importantly, we found that the expression recovery of the imprinted H19 gene was dependent on the methylation state in the differential methylation region (DMR). The induction of Nanog expression, however, was independent of the promoter region DNA methylation state in P19 NTES cells. A whole-genome transcriptome analysis further demonstrated that P19 NTES cells were indeed the intermediates between P19 cells and ES cells and many interesting genes were uncovered that may be responsible for the failed reprogramming of P19 cells. To our knowledge, for the first time, we linked incomplete reprogramming to the improved pluripotency of EC cell-derived pluripotent stem cells. The candidate genes we discovered may be useful not only for understanding the mechanisms of reprogramming, but also for deciphering the transition between tumorigenesis and pluripotency.

Unique Features of Mutations Revealed by Sequentially Reprogrammed Induced Pluripotent Stem Cells

A promising iPS-based single-cell cloning strategy revealing signatures of somatic mutations in heterogeneous normal cells.

Genetic heterogeneity of induced pluripotent stem cells: results from 24 clones derived from a single C57BL/6 mouse

Elevated coding mutation rate during the reprogramming of human somatic cells into induced pluripotent stem cells

Mouse SCNT ESCs Have Lower Somatic Mutation Load Than Syngeneic Ipscs.

Genome-wide CNV Analysis in Mouse Induced Pluripotent Stem Cells Reveals Dosage Effect of Pluripotent Factors on Genome Integrity

Comparable frequencies of coding mutations and loss of imprinting in human pluripotent cells derived by nuclear transfer and defined factors.

Generation of Induced Pluripotent Stem Cells Using Recombinant Proteins.

Low Incidence of DNA Sequence Variation in Human Induced Pluripotent Stem Cells Generated by Nonintegrating Plasmid Expression.

iPS cell generation-associated point mutations include many C > T substitutions via different cytosine modification mechanisms

Viable Fertile Mice Generated from Fully Pluripotent iPS Cells Derived from Adult Somatic Cells

Ips Cells Can Support Full-Term Development of Tetraploid Blastocyst-Complemented Embryos

High-throughput Sequencing Reveals the Disruption of Methylation of Imprinted Gene in Induced Pluripotent Stem Cells

Generation of Viable Mice from Induced Pluripotent Stem Cells (iPSCs) Through Tetraploid Complementation.

Reprogramme-induced genomic stability

Chromosomal aberration arises during somatic reprogramming to pluripotent stem cells

Abnormalities in Human Pluripotent Cells Due to Reprogramming Mechanisms

Linking Incomplete Reprogramming to the Improved Pluripotency of Murine Embryonal Carcinoma Cell-Derived Pluripotent Stem Cells

Chromosome Microduplication in Somatic Cells Decreases the Genetic Stability of Human Reprogrammed Somatic Cells and Results in Pluripotent Stem Cells

Residual undifferentiated cells during differentiation of induced pluripotent stem cells in vitro and in vivo.

Generation of Fully Pluripotent Female Murine-Induced Pluripotent Stem Cells.